Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera AB Resolves Rights Issue Of 157.4 Million Units

March 6 (Reuters) - Kancera AB  KANC.ST :
    * KANCERA AB - RESOLVES RIGHTS ISSUE OF 157.4 MILLION UNITS
    * KANCERA AB - SUBSCRIPTION PRICE IS 0,39 SEK PER UNIT
    * KANCERA AB - SUBSCRIPTION PERIOD 17 - 31 MARCH 2020
    * KANCERA AB - ISSUE ESTIMATED TO GENERATE PROCEEDS OF ABOUT SEK 61.4 MILLION BEFORE ISSUE
COSTS

Source text for Eikon:  ID:nWkr5QTJSp 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Novakand Pharma AB

See all news